Ratings
0
Nobody has rated this yet. Be the first!
Works
4
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
